Pierre Fabre plans to double manufacturing capability at Avène plant in France

Pierre Fabre introduced on Thursday, Could 28, a virtually EUR 50 million (USD 58 million) funding to double manufacturing capability at its Avène plant in southern France by 2029. The challenge will modernize and increase the power, which is totally devoted to manufacturing and packaging merchandise below the Eau Thermale Avène model, as the corporate seeks to satisfy sturdy worldwide demand, significantly in China and the US.

The Pierre Fabre Group goals to double the location’s annual manufacturing capability from 100 million to 200 million models by 2029.

The corporate stated the enlargement and modernization of the plant, devoted to its flagship skincare model, types a part of a broader EUR 250 million industrial funding program spanning 2023 to 2027.

The Avène unit, which employs 330 folks, homes manufacturing, packaging, and a warehouse, supplemented by two exterior logistics websites.

In 2025, Pierre Fabre generated EUR 3.2 billion in income, with worldwide markets accounting for 71% of gross sales. The group, which employs 10,000 folks worldwide, manufactures almost 90% of its merchandise in France.

The group’s dermo-cosmetics gross sales rose by 2.6% in contrast with 2024, pushed specifically by sturdy efficiency from the Eau Thermale Avène model, which grew 3.9% at fixed alternate charges over the 12 months.

Pierre Fabre’s dermo-cosmetics portfolio additionally consists of Ducray, Dexeryl, Klorane, A-Derma, René Furterer, Même Cosmetics, and Elgydium.